WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
Find important updates, industry news, and information on CLSI’s upcoming events. Check out past CLSI press releases, upcoming Committees Week, and newsworthy items.
January 30, 2023
The Clinical and Laboratory Standards Institute announces the recipients of its 2023 Excellence Awards. These awards celebrate the achievements of CLSI volunteers and organizational members who are committed to CLSI’s mission and have helped improve the quality of medical care worldwide. Recipients are recognized for dedicating significant time and effort to the development, implementation, and promotion of CLSI standards.
Read More
October 28, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published the 3rd Edition of EP19—A Framework for Using CLSI Documents to Evaluate Medical Laboratory Test Methods. The 3rd Edition of the EP19 Report is available free, and introduces the Test Life Phases Model, which points users to CLSI evaluation protocol documents to establish and implement commercially manufactured or laboratory-developed test (LDT) methods.
Read More
October 21, 2022
The Clinical and Laboratory Standards Institute (CLSI) has announced that a new and updated version of the I/LA37 Database, Supplemental Data for Allergen Specificity for IgE Antibody Autoanalyzers, is now available. The updated database provides essential allergen information for allergy testing manufacturers and hospitals performing allergy testing, both laboratories and clinicians. It includes a harmonized listing of the allergen codes currently used by immunoglobulin E antibody assay manufacturers, along with their common name, Latin name, and allergen grouping.
Read More
September 12, 2022
The Clinical and Laboratory Standards Institute (CLSI) announces that the Pan American Health Organization (PAHO) Member States have admitted CLSI into official relations as a non-state actor with PAHO for a period of three years (2022-2024). PAHO acts as the Regional Office for the Americas of the World Health Organization (WHO).
Read More
August 24, 2022
The Clinical and Laboratory Standards Institute (CLSI) has announced the publication of three new editions of antifungal documents: M57S—Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 4th Edition, M27M44S—Performance Standards for Antifungal Susceptibility Testing of Yeasts, 3rd Edition, and M38M51S—Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi, 3rd Edition.
Read More
August 15, 2022
The Clinical and Laboratory Standards Institute (CLSI) is excited to introduce Method Navigator, a comprehensive subscription resource that helps laboratories identify, understand, and meet regulatory requirements.
Read More
July 27, 2022
The Clinical and Laboratory Standards Institute has published the 4th Edition of EP14—Evaluation of Commutability of Processed Samples.
Read More
June 16, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of QMS15—Laboratory Internal Audit Program. This guideline provides recommendations for establishing an internal audit program and related processes for enhanced quality and continual improvement in the laboratory.
Read More
April 25, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of M47—Principles and Procedures for Blood Cultures.
Read More
April 12, 2022
Biotech executive, Barbara J. Jones, Ph.D., has been named Chief Executive Officer of the Clinical and Laboratory Standards Institute (CLSI) effective May 16, 2022. The current CLSI CEO, Glen Fine, announced his retirement in January 2022 and is set to depart the organization after 17 years at the helm.
Read More